KK2 - Take a look at corporate presentations from years gone by, (at least 5 years). RVX-297 rings a bell. RVX had 6 or 7 molecules in the lineup and I believe at least a couple of the were patented. Lack of funds to develope the portfolio has been a major stumbling block for sure as well as other things.
tada